Monopteros Therapeutics Is A Clinical Stage Biotechnology Company Developing A First In Class Inhibitor Of Malt1 Proteasethe Company S First Asset Mpt 0118Is Conducting A Phase 1 Clinical Trial To Investigate Reprogramming Regulatory T Cells In Solid Tumors
No conferences found for this company.
| Company Name | Monopteros Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
Enter your address and we will specify the offer for your area.